A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Diffuse Non-Hodgkin Lymphoma

Clinical trial NCT04232826 · COMPLETED

Trial details

NCT number: NCT04232826
Sponsor: Juventas Cell Therapy Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Non-Hodgkin Lymphoma

Start date: 2020-01-15
Primary completion: 2021-01-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.